Charles Schwab Investment Management Inc. Grows Stake in Semler Scientific, Inc. (NASDAQ:SMLR)

Charles Schwab Investment Management Inc. lifted its stake in Semler Scientific, Inc. (NASDAQ:SMLR) by 9.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 43,823 shares of the company’s stock after acquiring an additional 3,925 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Semler Scientific were worth $1,032,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Shariaportfolio Inc. acquired a new position in Semler Scientific during the 3rd quarter worth approximately $3,618,000. AQR Capital Management LLC raised its stake in shares of Semler Scientific by 150.1% during the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after purchasing an additional 84,314 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Semler Scientific by 18.3% during the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares in the last quarter. Citizens Financial Group Inc. RI acquired a new position in shares of Semler Scientific during the second quarter worth $585,000. Finally, Principal Financial Group Inc. purchased a new position in shares of Semler Scientific in the third quarter valued at $361,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Price Performance

Semler Scientific stock opened at $74.73 on Wednesday. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The company has a market capitalization of $619.44 million, a price-to-earnings ratio of 36.45 and a beta of 1.18. The firm’s fifty day moving average price is $44.80 and its 200 day moving average price is $35.13.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The company had revenue of $13.51 million during the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.